The Effect of Tranexamic Acid on Postpartum Hemorrhage During and After Cesarean Delivery
NCT ID: NCT01085006
Last Updated: 2011-01-25
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE1/PHASE2
100 participants
INTERVENTIONAL
2009-09-30
2010-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Reducing Blood Loss During Cesarean Section by Topical Versus IV Tranexamic Acid
NCT03706339
Effectiveness of Intravenous Tranexamic Acid in Reducing Blood Loss During and After Cesarean Section
NCT02279186
Tranexamic Acid in Preventing Postpartum Hemorrhage in High Risk Pregnancies During Elective Cesarean Section
NCT03351686
Tranexamic Acid and Thromboelastography During Cesarean Delivery
NCT02026297
Tranexamic Acid for Prevention of Hemorrhage in Cesarean Delivery
NCT03856164
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Tranexamic acid
Tranexamic acid
Tranexamic acid in cases, normal saline in controls
normal saline infusion
Normal saline
Tranexamic acid in cases, normal saline in controls
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Tranexamic acid
Tranexamic acid in cases, normal saline in controls
Normal saline
Tranexamic acid in cases, normal saline in controls
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Single fetus
3. Maximally only one previous cesarean delivery
Exclusion Criteria
2. Hx of other abdominal or pelvic surgery
3. Hx of medical disorders
4. Hx of thromboembolic disorders
5. Polyhydramnios
6. Macrosomia
7. Preeclampsia
8. Hx of sensitivity to Tranexamic acid
9. Abnormal Pt, PTT, PT or INR
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tehran University of Medical Sciences
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Associated Prof
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Laleh Eslamian, MD
Role: PRINCIPAL_INVESTIGATOR
Associated Prof, Obstetrician & Gynecologist
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Laleh Eslamian
Tehran, , Iran
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
830
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.